The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Intravesical drug delivery: Challenges, current status, opportunities and novel strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Biomedical applications of collagen
Lee, C. H., Singla, A., & Lee, Y. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00691-3 · Cited by 1,945
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
The basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., Kiemeney, L., Kriegmair, M., Montironi, R., Murphy, W. M., et al. (2005) · Urology · doi:10.1016/j.urology.2005.07.062 · Cited by 1,074
Kaufman, D. S., Shipley, W. U., & Feldman, A. S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60491-8 · Cited by 988
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 900
In Vitro Gene Delivery by Degraded Polyamidoamine Dendrimers
Tang, M. X., Redemann, C. T., & Szoka, F. C. (1996) · Bioconjugate Chemistry · doi:10.1021/bc9600630 · Cited by 808
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Antiangiogenic properties of silver nanoparticles
Gurunathan, S., Lee, K.-J., Kalishwaralal, K., Sheikpranbabu, S., Vaidyanathan, R., & Eom, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.008 · Cited by 562
Hyperthermia adds to chemotherapy
Issels, R. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.038 · Cited by 545
Zhang, X., Meng, L., Lu, Q., Fei, Z., & Dyson, P. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.025 · Cited by 536
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy
Pradhan, P., Giri, J., Rieken, F., Koch, C., Mykhaylyk, O., Döblinger, M., Banerjee, R., Bahadur, D., & Plank, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.002 · Cited by 468
Self-citationOosterlinck, W., Lobel, B., Jakse, G., Malmström, P.-U., Stöckle, M., & Sternberg, C. (2002) · European Urology · doi:10.1016/s0302-2838(01)00026-4 · Cited by 464
Introduction to nanotechnology and its applications to medicine
Silva, G. A. (2004) · Surgical Neurology · doi:10.1016/j.surneu.2003.09.036 · Cited by 383
Foldvari, M., & Bagonluri, M. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.04.003 · Cited by 378
Mechanisms of Disease: involvement of the urothelium in bladder dysfunction
Birder, L. A., & de Groat, W. C. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0672 · Cited by 364
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Kim, J.-H., Kim, Y.-S., Park, K., Lee, S., Nam, H. Y., Min, K. H., Jo, H. G., Park, J. H., Choi, K., Jeong, S. Y., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.014 · Cited by 350
New frontiers in nanotechnology for cancer treatment
Alexis, F., Rhee, J.-W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.017 · Cited by 347
Everything you wanted to know about the bladder epithelium but were afraid to ask
Lewis, S. A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.6.f867 · Cited by 335
Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes
Gaucher, G., Marchessault, R. H., & Leroux, J.-C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.012 · Cited by 315
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin
Subedi, R. K., Kang, K. W., & Choi, H.-K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.008 · Cited by 301
Injectable chitosan hydrogels for localised cancer therapy
Ta, H. T., Dass, C. R., & Dunstan, D. E. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.018 · Cited by 287
OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
Elstad, N. L., & Fowers, K. D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.010 · Cited by 286
Di Stasi, S. M., Giannantoni, A., Giurioli, A., Valenti, M., Zampa, G., Storti, L., Attisani, F., De Carolis, A., Capelli, G., Vespasiani, G., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70472-1 · Cited by 282
CHANCELLOR, M. B., & de GROAT, W. C. (1999) · Journal of Urology · doi:10.1097/00005392-199907000-00002 · Cited by 268
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Lu, Z., Yeh, T.-K., Tsai, M., Au, J. L.-S., & Wientjes, M. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1443 · Cited by 256
Patri, A. K., Myc, A., Beals, J., Thomas, T. P., Bander, N. H., & Baker, J. R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249
Bioconjugated quantum dots for cancer research: Present status, prospects and remaining issues
Biju, V., Mundayoor, S., Omkumar, R. V., Anas, A., & Ishikawa, M. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.11.007 · Cited by 243
Permeability properties of the intact mammalian bladder epithelium
Negrete, H. O., Lavelle, J. P., Berg, J., Lewis, S. A., & Zeidel, M. L. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.271.4.f886 · Cited by 217
Pinto Reis, C., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.04.009 · Cited by 215
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
Injectable block copolymer hydrogels for sustained release of a PEGylated drug
Yu, L., Chang, G. T., Zhang, H., & Ding, J. D. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.026 · Cited by 197
More than just a barrier: urothelium as a drug target for urinary bladder pain
Birder, L. A. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00467.2004 · Cited by 189
Yu, J., Lin, J., Wu, X., & Sun, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.125.1.171 · Cited by 186
Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases
Kong, X.-T., Deng, F.-M., Hu, P., Liang, F.-X., Zhou, G., Auerbach, A. B., Genieser, N., Nelson, P. K., Robbins, E. S., Shapiro, E., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406025 · Cited by 176
Diagnosis and management of superficial bladder cancer
Amling, C. L. (2001) · Current Problems in Cancer · doi:10.1067/mcn.2001.117539 · Cited by 170
Bilensoy, E., Sarisozen, C., Esendağlı, G., Doğan, A. L., Aktaş, Y., Şen, M., & Mungan, N. A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.015 · Cited by 164
Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs
Tan, A., Simovic, S., Davey, A. K., Rades, T., & Prestidge, C. A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.014 · Cited by 163
Kratz, F., Beyer, U., Roth, T. F., Tarasova, N. I., Collery, P., Lechenault, F., Cazabat, A., Schumacher, P., Unger, C., & Falken, U. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970246a · Cited by 156
Obata, Y., Tajima, S., & Takeoka, S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.023 · Cited by 140
Giannantoni, A., Costantini, E., Stasi, S. M. D., et al. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.002 · Cited by 134
Recent Advances in Intravesical Drug/Gene Delivery
Tyagi, P., Wu, P., Chancellor, M. B., et al. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060001j · Cited by 130
Gou, M., Li, X., Dai, M., Gong, C., Wang, X., Xie, Y., Deng, H., Chen, L., Zhao, X., Qian, Z., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.023 · Cited by 129
Bladder Defense Molecules, Urothelial Differentiation, Urinary Biomarkers, and Interstitial Cystitis
Hurst, R. E., Moldwin, R., & Mulholland, S. G. (2007) · Urology · doi:10.1016/j.urology.2006.03.083 · Cited by 123
Sustained Intravesical Drug Delivery Using Thermosensitive Hydrogel
Tyagi, P., Li, Z., Chancellor, M. B., de Groat, W. C., Yoshimura, N., & Huang, L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026436.62869.9c · Cited by 105
Saravanakumar, G., Min, K. H., Min, D. S., Kim, A. Y., Lee, C.-M., Cho, Y. W., Lee, S. C., Kim, K., Jeong, S. Y., Park, K., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.015 · Cited by 100
Mattheolabakis, G., Taoufik, E., Haralambous, S., Roberts, M. L., & Avgoustakis, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.011 · Cited by 98
Gloria, K., & Nie, S. (2005) · Materials Today · doi:10.1016/s1369-7021(05)71034-8 · Cited by 92
Clinical aspects of drug delivery to tumors
Au, J. L. ‐., Jang, S. H., & Wientjes, M. G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00488-6 · Cited by 85
Bos, G. W., Jacobs, J. J. L., Koten, J. W., Tomme, S. R. V., Veldhuis, T. F. J., van Nostrum, C. F., Otter, W. D., & Hennink, W. E. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.12.007 · Cited by 83
Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers
Leakakos, T., Ji, C., Lawson, G., Peterson, C., & Goodwin, S. C. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0597-9 · Cited by 79
Chang, L.-C., Wu, S.-C., Tsai, J., Yu, T.-J., & Tsai, T. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.045 · Cited by 70
Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium
Kerec-Kos, M., Bogataj, M., Veranič, P., & Mrhar, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.003 · Cited by 62
Intravesical therapy for bladder cancer
Kamat, A. M., & Lamm, D. L. (2000) · Urology · doi:10.1016/s0090-4295(99)00463-x · Cited by 60
Wang, Z., Itoh, Y., Hosaka, Y., Kobayashi, I., Nakano, Y., Maeda, I., Umeda, F., Yamakawa, J., Nishimine, M., Suenobu, T., et al. (2003) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(04)70146-2 · Cited by 51
Colombo, R., Salonia, A., Pozzo, L. D., Naspro, R. L., Freschi, M., Paroni, R. C., Pavone‐Macaluso, M., & Rigatti, P. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00076-3 · Cited by 39
Painful bladder syndrome/interstitial cystitis
Rosamilia, A. (2005) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2005.08.004 · Cited by 36
Soler, R., Bruschini, H., Martins, J. R. M., Dreyfuss, J. L., Câmara, N. O. S., Alves, M. T. D. S., Leite, K. R. M., Truzzi, J. C., Nader, H. B., Srougi, M., et al. (2008) · Urology · doi:10.1016/j.urology.2008.01.028 · Cited by 35
Interstitial cystitis/bladder pain syndrome: An update
Dasgupta, J., & Tincello, D. G. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.09.016 · Cited by 35
Drug delivery systems in urology—getting “smarter”
Farokhzad, O. C., Dimitrakov, J. D., Karp, J. M., Khademhosseini, A., Freeman, M. R., & Langer, R. (2006) · Urology · doi:10.1016/j.urology.2006.03.069 · Cited by 33
Liposomes, micelles and microemulsions as new delivery systems for cytotoxic alkaloids
Cortesi, R., & Nastruzzi, C. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00171-6 · Cited by 32
In vitro and in vivo evaluation of novel cationic liposomes utilized for cancer gene therapy
Serikawa, T., Kikuchi, A., Sugaya, S., Suzuki, N., Kikuchi, H., & Tanaka, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.001 · Cited by 29
Nanotechnology and Its Relevance to the Urologist
Gommersall, L. M., Shergill, I. S., Ahmed, H. U., Hayne, D., Arya, M., PATEL, H. R. H., Hashizume, M., & Gill, I. S. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.065 · Cited by 27
The Interstitial Cystitis Syndrome: Intravesical and Oral Treatment
Kurth, K. H., & Parsons, C. L. (2003) · European Urology Supplements · doi:10.1016/s1569-9056(03)00034-4 · Cited by 7
Urinary diversion and bladder substitution in patients with bladder cancer
Davidsson, T., Wullt, B., Könyves, J., Månsson, Å., & Månsson, W. (2000) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(00)00069-7 · Cited by 5
Cited by
A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4503 · Cited by 480
Mucoadhesive vs. mucopenetrating particulate drug delivery
Netsomboon, K., & Bernkop-Schnürch, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.003 · Cited by 318
Clinical therapies and nano drug delivery systems for urinary bladder cancer
Jain, P., Kathuria, H., & Momin, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107871 · Cited by 89
Metadata
- Authors
- GuhaSarkar, S., & Banerjee, R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 148
- Issue
- 2
- Pages
- 147-159
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2058870872
- Cited by
- 285
- References
- 74
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.